Global Nuclear Medicine Market 2018
22-Jun-2018 | Number of pages: 225 | Report Id: BMRC PH 127 | Report Format: | Status: Upcoming

Premium Insight of Global Nuclear Medicine Market 2018-2024

 

 

Brandessence Market Research is working on a new report titleGlobal Nuclear Medicine Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024″. Growing demand for advanced and accurate diagnostic techniques and effective treatment are fueling the market growth. Additionally, increasing incidences of cancer and cardiac ailments likely to enhance the growth of Global Nuclear Medicine Market.

 Scope of Global Nuclear Medicine Market Reports –

Nuclear medicine is a branch of medical imaging which uses very small amount of radioactive material (Radiopharmaceuticals) to diagnose and treat variety of disease such as various forms of cancers, heart disease, gastrointestinal, endocrine, neurological disorders, and other abnormalities within the body.In Nuclear Medicine imaging the radioisotopes are identified by the special type of cameras connected to the computer which offersactualimage of the body part which was examined. Nuclear Medicines are radioactive materials that are injected into bloodstream or are swallowed in small amount through which they can help in early detection of diseases. By using radioactive material with pharmaceutical compounds used to detect a definite organ for imaging purposes, to check the development of disease in the body, concentrating on cellular function and physiology of the body. Nuclear medicine includes treatment of diseased tissues. Therapeutic nuclear medicines or used to treat an overactive thyroid gland – a condition known as hyperthyroidism or thyrotoxicosis.

Nuclear Medicine helps to find medical information that is not easily available or requires surgical procedure or costly and invasive diagnostic tests. It helps in detection of symptoms at a very early stage of a disease.

Global Nuclear Medicine Market has been segmented on the basis of Type, Procedural Volumes, Application, End User and Geography. On the basis ofType of Global Nuclear Medicine Market is classified into Diagnostic Nuclear Medicine,Therapeutic Nuclear Medicine, Research Nuclear Medicine and Other.On the basis of Procedural Volumes of Global Nuclear Medicine Market is classified intoDiagnostic Procedures,Therapeutic Procedures and Other.On the basis of ApplicationGlobal Nuclear Medicine Market is classified intoOncology,Cardiology, Neurology, Thyroid, Lymphoma, Endocrinology and others.On the basis of End User Global Nuclear Medicine Market is classified intodiagnostic centers, hospitals, research centers and others.  The regions covered in Global Nuclear Medicine Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Nuclear Medicine Market Reports –

Global Nuclear Medicine Market reports cover prominent players like Cardinal Health Inc., Mallinckrodt plc, GE Healthcare, Lantheus Medical Imaging, Inc., Bayer AG, Bracco Imaging S.p.A, Eczacibasi-Monrol Nuclear Products, Advanced Accelerator Applications S.A., IBA Molecular Imaging, Mallinckrodt plc, Cardinal Health Inc., Curium, Lantheus Medical Imgaging, Triad Isotopes, Siemens Healthineer, Bracco, Cambridge Isotope Laboratories Inc., Nordion Inc., Fujifilm Holdings Corporation, Philips Healthcare, Digirad, Ashby Gorman Baker Ltd, Lantheus Medical Imaging Inc., Jubilant Life Sciences and NTP Radioisotopes SOC Ltd.

 Global Nuclear Medicine Market Dynamics –

Growth of the overallGlobal Nuclear Medicine Market can be attributed to factors such as the increasing incidences of cancer and cardiovascular disorders, development of alpha radiotherapy and funds through public-private partnerships.Growing occurrence of cardiac patients and acceptance of clear imaging method, with the help of diagnostic equipment such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography). Moreover, themanufacture of MO-99 in the U.S. approval of Nuclear Medicine by the FDA, new irradiation capacity in Germany, system of PET scanners in India, funds by the government in the Rest of Asia-Pacific and initiatives of IAEA (International Atomic Energy Agency) is enhancing theGlobal Nuclear Medicine Market.The factors that restrain the growth of the Global Nuclear Medicine Market includeHigh cost of medicinessuch asmore than $100 million, supply shortages, logistical difficulties and limited number of trained medical personnel.Also, stringent government regulation for drug approval are keyreasonshindering growth of the Global Nuclear Medicine Market.Furthermore, reimbursement obstacles for the manufacturer and high money investment are also restraining the Global Nuclear Medicine Market growth. Moreover, advancements in scanning technology are increasing the effectiveness of diagnosis using radioisotopes and as a consequence application areas of current radioisotopes are quickly growing. Extensiveuses of the existing products united with introduction of newer radioisotopes for the diagnosis of respiratory, bones and thyroid related diseases are increasing the growth of nuclear medicines in the Global Nuclear Medicine Market.

High accurateness, capacity to integrate with other diagnostic techniques such as x-ray and growing awareness of this technique in the developing market are the main factors likely to fuel the market growth of the diagnostic nuclear medicines during the forecast period.

Global Nuclear Medicine Market Regional Analysis –

From a geographical standpoint, North America is the dominant market in 2017and occupied around 40% of the overall market revenue. In North America the United States is the major consumer market for Nuclear Medicine and Canada is the largest producer of Tc-99m.It is due to the widespread awareness of the use of radioisotopes and radiation in medicine for various medical conditions. In the developed countries, the frequency of diagnostic and therapeutic nuclear medicine is rising exponentially. Asia Pacific is projected to outshine all other regions in the upcoming years, mainly driven by Japan, China, Australia, and India nations where the fastest growth in the region are rising healthcare spending and increasing awareness of Nuclear Medicine among healthcare providers. The huge population, increasing occurrences of neurological and cardiovascular diseases as well as various types of cancer is also contributory to the growth of Global Nuclear Medicine Market in Asia Pacific.

Key Benefits for Global Nuclear Medicine Market Reports –

  • Global Nuclear Medicine Market report covers in depth historical and forecast analysis.
  • Global Nuclear Medicine Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Nuclear Medicine Market report helps to identify opportunities in market place.
  • Global Nuclear Medicine Market report covers extensive analysis of emerging trends and competitive landscape.

 Global Nuclear Medicine Market Segmentation

 Global Nuclear Medicine Market: By Type Analysis

  • Diagnostic Nuclear Medicine
  • Therapeutic Nuclear Medicine
  • Research Nuclear Medicine
  • Other

Global Nuclear Medicine Market: By Procedural Volumes Analysis

  • Diagnostic Procedures
  • Therapeutic Procedures
  • Other

Global Nuclear Medicine Market: By Application Analysis

  • Oncology
  • Cardiology
  • Neurology
  • Thyroid
  • Lymphoma
  • Endocrinology
  • Other

Global Nuclear Medicine Market: By End User Analysis

  • Diagnostic Centres
  • Hospitals
  • Research Centres
  • Other

Global Nuclear Medicine Market: By Regional & Country Analysis

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

 

 

 

 

Global Nuclear Medicine Market 2018-2024

Our 225 pages report provides 63tables, 87 charts and graphs. The report covers historical and forecast data of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Our study focuses on the most lucrative areas in the industry and the future market prospects. Market covers financial results, trends, opportunities and revenue predictions from 2018 to 2024. Significant rise in research and development activities by leading vendors.

Why you should buy this report:

  • To receive a comprehensive analysis of the prospects for Global Nuclear Medicine Market
  • To receive forecasts of Global Nuclear Medicine Market Sales in leading country markets from 2018-2024, including leading and emerging country from developed and developing regions
  • To discover the views of experts in theGlobal Nuclear Medicine Market sector
  • To determine the forces and factor that influences the market forGlobal Nuclear Medicine Market: drivers, restraints, opportunities and threats
  • To find out where the Global Nuclear Medicine Market is heading – both technologically and commercially from 2018-2024
  • Report Include tables of contract/projects and its value and description by  region and Country

Global Nuclear Medicine Market: By Region Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Global XX XX XX XX XX
North America XX XX XX XX XX
Europe XX XX XX XX XX
Asia Pacific XX XX XX XX XX
Latin America XX XX XX XX XX
Middle East & Africa XX XX XX XX XX
Global XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Nuclear Medicine Market: By Type Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Diagnostic Nuclear Medicine XX XX XX XX XX
Therapeutic Nuclear Medicine XX XX XX XX XX
Research Nuclear Medicine XX XX XX XX XX
Other XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Nuclear Medicine Market: By Procedural Volumes Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Diagnostic Procedures XX XX XX XX XX
Therapeutic Procedures XX XX XX XX XX
Other XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Nuclear Medicine Market: By Application Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Oncology XX XX XX XX XX
Cardiology XX XX XX XX XX
Neurology XX XX XX XX XX
Thyroid XX XX XX XX XX
Lymphoma XX XX XX XX XX
Endocrinology XX XX XX XX XX
Other XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Nuclear Medicine Market: By End User Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Diagnostic Centres XX XX XX XX XX
Hospitals XX XX XX XX XX
Research Centres XX XX XX XX XX
Other XX XX XX XX XX

Source: Brandessence Market Research, 2018

Why You Must Buy This Report:

This report features news, insights, the latest developments and an in depth survey ofGlobal Nuclear Medicine Market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors.

Email me today to order this report or to ask for assistance. I look forward to receiving your email on sales@brandessenceresearch.com

 Companies Mentioned in This Report,

  • Advanced Accelerator Applications S.A.
  • Ashby Gorman Baker Ltd
  • Bayer AG
  • Bracco Imaging S.p.A
  • Cambridge Isotope Laboratories Inc.
  • Cardinal Health Inc.
  • Curium
  • Digirad
  • Eczacibasi-Monrol Nuclear Products
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • IBA Molecular Imaging
  • Jubilant Life Sciences
  • Lantheus Medical ImagingInc.
  • Mallinckrodt plc
  • Nordion Inc.
  • NTP Radioisotopes SOC Ltd.
  • Philips Healthcare
  • Siemens Healthineer
  • Triad Isotopes
  • Others

 

 

Table of Content

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Nuclear Medicine Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Nuclear Medicine Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Global Nuclear Medicine Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  1. Chapter – Global Nuclear Medicine Market Overview: Quantitative Analysis
    • Global Nuclear Medicine Market Production (K Unit), Market Share (%) and Growth Rate (%), 2014- 2024
    • Global Nuclear Medicine Market Consumption (K Unit), Market Share ( %) and Growth Rate, 2014- 2024
    • Global Nuclear Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024
  2. Chapter –Global Nuclear Medicine Market: by Type
  3. Chapter –Global Nuclear Medicine Market: by Procedural Volumes
  4. Chapter –Global Nuclear Medicine Market: by Application
  5. Chapter –Global Nuclear Medicine Market: by End User
    • Global Nuclear Medicine Market (USD Million), by Manufacturer, 2014 – 2024
    • Global Nuclear Medicine Market Production (K Unit), by Manufacturer, 2014 – 2024
    • Global Nuclear Medicine Market Consumption (K Unit), Manufacturer, 2014 – 2024
    • Global Nuclear Medicine Market Share (%), by Manufacturer, 2017
    • Global Nuclear Medicine Market Price (USD/Unit), by Manufacturer, 2014 – 2024
    • Global Nuclear Medicine Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
    • Merger & Acquisition
    • Collaborations and Partnership
    • New Product Launch
  6. Chapter -Global Nuclear Medicine Market: Regional Analysis
    • North America
    • North America Global Nuclear Medicine Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024.
    • North America Global Nuclear Medicine Market Revenue (USD Million) By Country, 2014 – 2024.
    • North America Global Nuclear Medicine Market Revenue Market Share (%) By Country, 2014 – 2024.
    • North America Global Nuclear Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Nuclear Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North AmericaGlobal Nuclear Medicine Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  7. Chapter – Company Profiles
    • Advanced Accelerator Applications S.A.
      • Overview
      • Financials
      • Product portfolio
      • Global Nuclear Medicine Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
      • Global Nuclear Medicine Market Share (%), 2014 – 2017
      • Business Overview
    • Ashby Gorman Baker Ltd
    • Bayer AG
    • Bracco Imaging S.p.A
    • Cambridge Isotope Laboratories Inc.
    • Cardinal Health Inc.
    • Curium
    • Digirad
    • Eczacibasi-Monrol Nuclear Products
    • Fujifilm Holdings Corporation
    • GE Healthcare
    • IBA Molecular Imaging
    • Jubilant Life Sciences
    • Lantheus Medical Imaging Inc.
    • Mallinckrodt plc
    • Nordion Inc.
    • NTP Radioisotopes SOC Ltd.
    • Philips Healthcare
    • Siemens Healthineer
    • Triad Isotopes
    • Other
  8. Chapter – Market Research and Findings

 

 

  • Advanced Accelerator Applications S.A.
  • Ashby Gorman Baker Ltd
  • Bayer AG
  • Bracco Imaging S.p.A
  • Cambridge Isotope Laboratories Inc.
  • Cardinal Health Inc.
  • Curium
  • Digirad
  • Eczacibasi-Monrol Nuclear Products
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • IBA Molecular Imaging
  • Jubilant Life Sciences
  • Lantheus Medical ImagingInc.
  • Mallinckrodt plc
  • Nordion Inc.
  • NTP Radioisotopes SOC Ltd.
  • Philips Healthcare
  • Siemens Healthineer
  • Triad Isotopes
  • Others